Guangzhou South China Agricultural University Biopharmaceutical Co., Ltd. is dedicated to the research and development, production, sales, and technical services of animal biological products for prevention, diagnosis, and treatment. It is a high-tech enterprise with independent legal entities and a designated manufacturer of highly pathogenic avian influenza vaccines by the Ministry of Agriculture.

（1） Enterprise production scale

The company was established in December 2004 and is located in the high-tech industrial base of Zengcheng District, Guangzhou City. It covers an area of about 50 acres and currently has three GMP production workshops for inactivated avian influenza vaccines, inactivated embryonic virus vaccines, and inactivated cell virus vaccines that have passed the GMP inspection of the Ministry of Agriculture. The annual production of various animal biological products is 5 billion feathers, making it a large-scale modern animal biological product production base in South China. Establish a laboratory animal center that has passed the acceptance inspection of the Guangdong Provincial Department of Science and Technology, and obtain a license for the use of experimental animals.

（2） Industry university research cooperation promotes new product research and development

Since its establishment, we have closely cooperated with the School of Veterinary Medicine of South China Agricultural University to establish a new model of industry university research cooperation. We have also collaborated with South China Agricultural University to apply reverse genetic operation technology to successfully develop recombinant avian influenza virus (H5+H7) trivalent inactivated vaccines (H5N2 rHN5801 strain+rGD59 strain, H7N9 rHN7903 strain), avian influenza virus H5 subtype inactivated vaccines (D7 strain+rD8 strain), and avian influenza inactivated vaccines (H5N2 subtype, D7 strain) targeting the mutation of avian influenza virus, making outstanding contributions to the prevention and control of avian diseases and healthy breeding in China.

At the same time, the company focuses on high-tech vaccines and strengthens cooperation with universities and research institutes. It has successively signed new product cooperation and intellectual property exclusive license agreements with universities and research institutions such as South China Agricultural University, Veterinary Research Institute of the PLA Military Medical Research Institute, China Agricultural University, Shandong Agricultural University, Henan Agricultural University, Guangdong Academy of Agricultural Sciences, Shanghai Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, and Animal Husbandry and Veterinary Research Institute of the Fujian Academy of Agricultural Sciences. It strengthens the research and development of new technologies, processes, and products, establishes strategic partnerships, and jointly undertakes projects such as the "13th Five Year Plan", "National Spark Program", "National Agricultural Science and Technology Achievement Transformation Fund Project", and "National Small and Medium Enterprise Development Special Fund Project". More than 10 scientific research projects at or above the provincial level, And has won several provincial-level and above scientific and technological progress awards, including the first prize of the 2017 Guangdong Provincial Science and Technology Award for "Research and Application of Key Technologies for Prevention and Control of Important Animal Derived zoonotic Diseases", and the first prize of the 2016 National Agriculture, Animal Husbandry and Fisheries Harvest Award for "Application and Promotion of Comprehensive Prevention and Control Technology for Waterfowl and Avian Influenza".

（3） Provide poultry industry disease prevention and control products

Our main products include: recombinant avian influenza virus (H5+H7) trivalent inactivated vaccine (H5N2 rHN5801 strain+rGD59 strain, H7N9 rHN7903 strain), avian influenza inactivated vaccine (H9 subtype, SS strain), chicken Newcastle disease virus (La Sota strain), avian influenza virus (H9 subtype, SS strain) dual inactivated vaccine, chicken Newcastle disease virus, infectious bronchitis avian influenza (H9 subtype) triple inactivated vaccine (La Sota strain+M41 strain+SS strain), and eight other products. The inactivated avian influenza vaccine (H5N2 subtype, D7 strain) obtained a new veterinary drug certificate issued by the Ministry of Agriculture in 2013 [(2013) New Veterinary Drug Certificate No. 12], and the inactivated avian influenza virus H5 subtype vaccine (D7 strain+rD8 strain) obtained a new veterinary drug certificate issued by the Ministry of Agriculture in 2017 [(2017) New Veterinary Drug Certificate No. 10]. The recombinant avian influenza virus (H5+H7) trivalent inactivated vaccine (H5N2 rHN5801 strain+rGD59 strain, H7N9 rHN7903 strain) obtained a new veterinary drug registration certificate (certificate number: (2021) New Veterinary Drug Certificate No. 67) in 2021.

（4） Innovation drives enterprise development

Taking innovation as our responsibility, we have established the "South China Biopharmaceutical Innovation Research Institute" and the "Academician Expert Enterprise Workstation". The institute has set up multiple research platforms, including the Avian Influenza Technology Center, Cell Engineering Technology Center, Animal Disease Detection Center, Process Technology Research Center, and Experimental Animal Center, to provide guarantees for the research and development of animal biological products and technical services. We currently have a research and development team of 56 people, including 6 with senior professional titles and 35 with doctoral and master's degrees. We apply advanced biological technologies to develop new vaccines and improve process technology, such as the recombinant avian influenza vaccine constructed by reverse genetic operation technology, suspension cell culture technology, and other fields. In response to the problems in the poultry industry, we carry out targeted scientific research activities guided by demand, linked by projects, and based on service. We have successively won the construction of platforms such as "High tech Enterprise", "National Model Academician Expert Enterprise Workstation", "Guangdong Engineering Laboratory", "Guangdong Engineering Technology Center", "Guangdong Provincial Enterprise Technology Center", "Guangdong Province Small and Medium Enterprise Innovation Industrialization Demonstration Base", and "Guangdong Province Key Agricultural Leading Enterprise". And honorary titles.

The intellectual property management system certification company adheres to the corporate philosophy of "quality is life, management creates benefits", strictly organizes production in accordance with GMP standards and job SOPs, strives for excellence, develops a complete set of quality control processes, implements blind spot quality management, produces high-quality and efficient products, and creates good economic and social benefits.

The company adheres to the development purpose of technological innovation, closely follows the School of Veterinary Medicine of South China Agricultural University, is based on high-tech biotechnology, takes it as its responsibility to develop the national animal biological products industry, maintain the national epidemic prevention system, establish a modern enterprise system, enhance the core competitiveness of the enterprise, and strive to become a benchmark in China's animal biological products industry.